• Citer

Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer: Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance

par Viale, Giuseppe;Dell’Orto, Patrizia;Glas, Annuska M;Cardoso, Fatima ;Slaets, Leen;de Snoo, Femke F.A.;Bogaerts, Jan;Russo, Leila;Van't Veer, Laura;Rutgers, Emiel Th;Piccart-Gebhart, Martine ;Stork-Sloots, Lisette
Référence Breast cancer research and treatment, 155, 3, page (463-469)
Publication Publié, 2016-02

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer: Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance
Auteur:	Viale, Giuseppe; Dell’Orto, Patrizia; Glas, Annuska M; Cardoso, Fatima; Slaets, Leen; de Snoo, Femke F.A.; Bogaerts, Jan; Russo, Leila; Van't Veer, Laura; Rutgers, Emiel Th; Piccart-Gebhart, Martine; Stork-Sloots, Lisette
Informations sur la publication:	Breast cancer research and treatment, 155, 3, page (463-469)
Statut de publication:	Publié, 2016-02
Sujet CREF:	Cancérologie
Mots-clés:	Breast cancer
	Concordance
	ER
	Gene expression
	HER2
	Hormone receptor
	IHC/FISH
	PgR
	TargetPrint
	Tumor heterogeneity
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0167-6806
	info:doi/10.1007/s10549-016-3690-6
	info:scp/84959089025